Da Hee Han, PharmD

The FDA has approved CaroSpir, the first oral liquid formulation of spironolactone for hypertension and heart failure treatment.

The FDA has approved Zypitamag for the treatment of patients with primary hyperlipidemia or mixed dyslipidemia.

Novo Nordisk submitted an application to the FDA with data on the cardiovascular safety of an insulin degludec.

New reports found that 70% of home blood pressure monitor readings are inaccurate.

A cerebrovascular event in a young, healthy, male patient was found to be associated with the use of exogenous testosterone.

A Cochrane review examined whether or not uric acid-lowering therapies could effectively reduce hypertension.

Patients with atrial fibrillation taking apixaban showed significantly less intracranial hemorrhage compared with patients taking warfarin.

Researchers found that use of NSAIDs like naproxen and ibuprofen were linked to increased out-of-hospital cardiac arrest risk.

Researchers conducted a meta-analysis to compare the safety and efficacy of sotalol vs amiodarone or beta-blockers to prevent supraventricular arrhythmias.

Researchers studied the safety and efficacy of cangrelor in patients receiving unfractionated heparin for PCI.